| Year |
Citation |
Score |
| 2023 |
Guo H, Vuille JA, Wittner BS, Lachtara EM, Hou Y, Lin M, Zhao T, Raman AT, Russell HC, Reeves BA, Pleskow HM, Wu CL, Gnirke A, Meissner A, Efstathiou JA, ... ... Miyamoto DT, et al. DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs. Cell. PMID 37327786 DOI: 10.1016/j.cell.2023.05.028 |
0.484 |
|
| 2022 |
Madueke I, Lee RJ, Miyamoto DT. Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers. The Urologic Clinics of North America. 50: 109-114. PMID 36424075 DOI: 10.1016/j.ucl.2022.09.010 |
0.321 |
|
| 2022 |
Karabacak NM, Zheng Y, Dubash TD, Burr R, Micalizzi DS, Wittner BS, Lin M, Wiley DF, Comaills V, Emmons E, Niederhoffer KL, Ho U, Ukleja J, Che D, Stowe H, ... ... Miyamoto DT, et al. Differential kinase activity across prostate tumor compartments defines sensitivity to target inhibition. Cancer Research. PMID 35045985 DOI: 10.1158/0008-5472.can-21-2609 |
0.525 |
|
| 2020 |
Miyamoto DT, Lee RJ. PIK Carefully, AKT Accordingly: Towards Precision Medicine in Prostate Cancer. European Urology. PMID 32900554 DOI: 10.1016/J.Eururo.2020.08.034 |
0.345 |
|
| 2020 |
de Jong JJ, Boormans JL, van Rhijn BWG, Seiler R, Boorjian SA, Konety B, Bivalacqua TJ, Wheeler T, Svatek RS, Douglas J, Wright J, Dall'Era M, Crabb SJ, Efstathiou JA, van der Heijden MS, ... ... Miyamoto DT, et al. Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences. European Urology Oncology. PMID 32205136 DOI: 10.1016/J.Euo.2020.02.010 |
0.374 |
|
| 2019 |
Fisher RR, Pleskow HM, Bedingfield K, Miyamoto DT. Noncanonical Wnt as a prognostic marker in prostate cancer: "You can't always get what you Wnt". Expert Review of Molecular Diagnostics. PMID 31814454 DOI: 10.1080/14737159.2020.1702522 |
0.382 |
|
| 2019 |
Batista da Costa J, Gibb EA, Bivalacqua TJ, Liu Y, Oo HZ, Miyamoto DT, Alshalalfa M, Davicioni E, Wright JL, Dall'Era M, Douglas J, Boormans JL, van der Heijden MS, Wu CL, van Rhijn BW, et al. Molecular characterization of neuroendocrine-like bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30952638 DOI: 10.1158/1078-0432.Ccr-18-3558 |
0.354 |
|
| 2019 |
Zheng Y, Comaills V, Burr R, Boulay G, Miyamoto DT, Wittner BS, Emmons E, Sil S, Koulopoulos MW, Broderick KT, Tai E, Rengarajan S, Kulkarni AS, Shioda T, Wu CL, et al. COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. PMID 30819896 DOI: 10.1073/Pnas.1819303116 |
0.583 |
|
| 2019 |
Efstathiou JA, Mouw KW, Gibb EA, Liu Y, Wu CL, Drumm MR, da Costa JB, du Plessis M, Wang NQ, Davicioni E, Feng FY, Seiler R, Black PC, Shipley WU, Miyamoto DT. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer. European Urology. PMID 30712971 DOI: 10.1016/J.Eururo.2019.01.011 |
0.309 |
|
| 2019 |
Costa JBD, Gibb EA, Bivalacqua TJ, Liu Y, Oo HZ, Miyamoto DT, Alshalalfa M, Davicioni E, Wright J, Dall’Era MA, Douglas J, Boormans L, Heijden MSVD, Wu C, Rhijn BWGV, et al. Molecular characterization of neuroendocrine-like bladder cancer European Urology Supplements. 18. DOI: 10.1016/S1569-9056(19)30464-6 |
0.355 |
|
| 2019 |
Kamran S, Yeap B, Pleskow H, Potter S, Nisbet S, Fisher R, Silvia B, Olsen C, Zietman A, Efstathiou J, Miyamoto D. Prospective Validation of Single Nucleotide Polymorphisms as Predictors of Rectal Toxicity Following Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E284-E285. DOI: 10.1016/J.Ijrobp.2019.06.1819 |
0.337 |
|
| 2019 |
Hwang W, Pleskow H, Czapla JAA, Fisher R, Kamran S, Lee R, Saylor P, Zietman A, Silvia B, Ting D, Maheswaran S, Haber D, Efstathiou J, Miyamoto D. Integrated Gene Expression Score in Circulating Tumor Cells to Predict Treatment Response in Muscle-Invasive Bladder Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E663. DOI: 10.1016/J.Ijrobp.2019.06.1060 |
0.55 |
|
| 2018 |
Miyamoto DT, Mouw KW, Feng FY, Shipley WU, Efstathiou JA. Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer. The Lancet. Oncology. 19: e683-e695. PMID 30507435 DOI: 10.1016/S1470-2045(18)30693-4 |
0.346 |
|
| 2018 |
Kwan TT, Bardia A, Spring LM, Giobbie-Hurder A, Kalinich M, Dubash T, Sundaresan T, Hong X, LiCausi JA, Ho U, Silva EJ, Wittner BS, Sequist LV, Kapur R, Miyamoto DT, et al. A digital RNA signature of Circulating Tumor Cells predicting early therapeutic response in localized and metastatic breast cancer. Cancer Discovery. PMID 30104333 DOI: 10.1158/2159-8290.Cd-18-0432 |
0.556 |
|
| 2018 |
Hong X, Sullivan RJ, Kalinich M, Kwan TT, Giobbie-Hurder A, Pan S, LiCausi JA, Milner JD, Nieman LT, Wittner BS, Ho U, Chen T, Kapur R, Lawrence DP, Flaherty KT, ... ... Miyamoto DT, et al. Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 29453278 DOI: 10.1073/Pnas.1719264115 |
0.556 |
|
| 2018 |
Hwang WL, Pleskow HM, Miyamoto DT. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration. Advanced Drug Delivery Reviews. PMID 29326053 DOI: 10.1016/J.Addr.2018.01.003 |
0.431 |
|
| 2018 |
Miyamoto DT, Lee RJ, Kalinich M, LiCausi J, Zheng Y, Chen T, Milner JD, Emmons E, Ho U, Broderick K, Silva E, Javaid S, Kwan TT, Hong X, Dahl DM, et al. An RNA-based digital circulating tumor cell signature is predictive of drug response and early dissemination in prostate cancer. Cancer Discovery. PMID 29301747 DOI: 10.1158/2159-8290.Cd-16-1406 |
0.576 |
|
| 2018 |
Miyamoto DT, Gibb E, Mouw KW, Liu Y, Wu C, Drumm M, Lehrer J, Ashab HA, Erho N, Du Plessis M, Ong K, Shipley WU, Davicioni E, Efstathiou JA. Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy. Journal of Clinical Oncology. 36: 513-513. DOI: 10.1200/Jco.2018.36.6_Suppl.513 |
0.35 |
|
| 2018 |
Hong X, Sullivan RJ, Kalinich M, Kwan T, Pan S, LiCausi JA, Milner JD, Nieman LT, Wittner BS, Ho U, Chen T, Kapur R, Lawrence D, Flaherty KT, Sequist LV, ... ... Miyamoto DT, et al. Abstract LB-144: Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-144 |
0.571 |
|
| 2018 |
Miyamoto D, Gibb E, Mouw K, Liu Y, Wu C, Drumm M, Lehrer J, Ashab H, Erho N, Du Plessis M, Ong K, Shipley W, Davicioni E, Efstathiou J. OC-0049: Genomic profiling of muscle invasive bladder cancer to predict response to chemoradiation therapy Radiotherapy and Oncology. 127: S21. DOI: 10.1016/S0167-8140(18)30359-1 |
0.306 |
|
| 2018 |
Miyamoto D, Fisher R, Pleskow H, Milner J, Kalinich M, Potter S, Quilty J, Toner M, Maheswaran S, Haber D, Zietman A, Efstathiou J. Prospective Evaluation of a Digital RNA Circulating Tumor Cell Signature in Localized Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e173-e174. DOI: 10.1016/J.Ijrobp.2018.07.648 |
0.581 |
|
| 2017 |
Wong KHK, Tessier SN, Miyamoto DT, Miller KL, Bookstaver LD, Carey TR, Stannard CJ, Thapar V, Tai EC, Vo KD, Emmons ES, Pleskow HM, Sandlin RD, Sequist LV, Ting DT, et al. Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells. Nature Communications. 8: 1733. PMID 29170510 DOI: 10.1038/S41467-017-01705-Y |
0.583 |
|
| 2017 |
Miyamoto DT, Ting DT, Toner M, Maheswaran S, Haber DA. Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity. Cold Spring Harbor Symposia On Quantitative Biology. PMID 28389596 DOI: 10.1101/Sqb.2016.81.031120 |
0.582 |
|
| 2017 |
Zheng Y, Miyamoto DT, Wittner BS, Sullivan JP, Aceto N, Jordan NV, Yu M, Karabacak NM, Comaills V, Morris R, Desai R, Desai N, Emmons E, Milner JD, Lee RJ, et al. Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination. Nature Communications. 8: 14344. PMID 28181495 DOI: 10.1038/Ncomms14344 |
0.553 |
|
| 2017 |
Kalinich M, Bhan I, Kwan TT, Miyamoto DT, Javaid S, LiCausi JA, Milner JD, Hong X, Goyal L, Sil S, Choz M, Ho U, Kapur R, Muzikansky A, Zhang H, et al. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 28096363 DOI: 10.1073/Pnas.1617032114 |
0.538 |
|
| 2017 |
Efstathiou JA, Gibb E, Miyamoto DT, Wu C, Drumm M, Lehrer J, Ashab HA, Erho N, du Plessis M, Ong K, Bhat A, Mouw KW, Davicioni E, Shipley WU. Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy. Journal of Clinical Oncology. 35: 287-287. DOI: 10.1200/Jco.2017.35.6_Suppl.287 |
0.357 |
|
| 2017 |
Maheswaran S, Kalinich M, Bhan I, Miyamoto D, Zheng Y, Hong X, Kwan TT, Kapur R, Sequist L, Sullivan R, Bardia A, Lee R, Ting D, Toner M, Haber DA. Abstract SY24-01: High-throughput CTC detection for noninvasive cancer monitoring Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Sy24-01 |
0.619 |
|
| 2017 |
Kwan TT, Bardia A, Sundaresan T, Spring L, Kalinich M, Miyamoto D, Hong X, LiCausi J, Ho U, Javaid S, Silva E, Sequist L, Maheswaran S, Haber D. Abstract 1736: A novel RNA-based assay for the detection and monitoring of circulating tumor cell signatures in breast cancer Cancer Research. 77: 1736-1736. DOI: 10.1158/1538-7445.Am2017-1736 |
0.598 |
|
| 2017 |
Kalinich M, Bhan I, Kwan TT, Miyamoto DT, Javaid S, LiCausi JA, Milner JD, Hong X, Goyal L, Sil S, Choz M, Kapur R, Muzikansky A, Zhang H, Weitz DA, et al. Abstract 1734: Absolute quantification of circulating tumor cell RNA enables high specificity detection of hepatocellular carcinoma Cancer Research. 77: 1734-1734. DOI: 10.1158/1538-7445.Am2017-1734 |
0.554 |
|
| 2017 |
Comaills V, Kabeche L, Morris R, Yu M, Madden MW, LiCausi JA, Aceto N, Zheng Y, Miyamoto DT, Ramaswamy S, Zou L, Haber DA, Maheswaran S. Abstract 1410: Proliferation during epithelial-to-mesenchymal transition induces genomic instability Cancer Research. 77: 1410-1410. DOI: 10.1158/1538-7445.Am2017-1410 |
0.448 |
|
| 2017 |
Miyamoto D, Drumm M, Clayman R, Niemierko A, Heney N, Lee R, Zietman A, Shipley W, Efstathiou J. Outcomes and Tolerability of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer in Elderly Patients International Journal of Radiation Oncology*Biology*Physics. 99: S120. DOI: 10.1016/J.Ijrobp.2017.06.282 |
0.322 |
|
| 2017 |
Efstathiou J, Gibb E, Miyamoto D, Wu C, Drumm M, Lehrer J, Ashab H, Erho N, du Plessis M, Ong K, Bhat A, Mouw K, Davicioni E, Shipley W. Subtyping Muscle-Invasive Bladder Cancer to Assess Clinical Response to Trimodality Therapy International Journal of Radiation Oncology*Biology*Physics. 99: S118. DOI: 10.1016/J.Ijrobp.2017.06.278 |
0.316 |
|
| 2016 |
Comaills V, Kabeche L, Morris R, Buisson R, Yu M, Madden MW, LiCausi JA, Boukhali M, Tajima K, Pan S, Aceto N, Sil S, Zheng Y, Sundaresan T, Yae T, ... Miyamoto DT, et al. Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition. Cell Reports. 17: 2632-2647. PMID 27926867 DOI: 10.1016/J.Celrep.2016.11.022 |
0.582 |
|
| 2016 |
Hwang WL, Hwang KL, Miyamoto DT. The promise of circulating tumor cells for precision cancer therapy. Biomarkers in Medicine. PMID 27924634 DOI: 10.2217/Bmm-2016-0192 |
0.446 |
|
| 2016 |
Miyamoto DT, Lee RJ. Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine? Urologic Oncology. PMID 27771279 DOI: 10.1016/J.Urolonc.2016.09.001 |
0.449 |
|
| 2016 |
Saylor PJ, Lee RJ, Arora KS, Deshpande V, Hu R, Olivier K, Meneely E, Rivera MN, Ting DT, Wu CL, Miyamoto DT. Branched chain RNA in situ hybridization for androgen receptor splice variant AR-V7 as a prognostic biomarker for metastatic castration-sensitive prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27440270 DOI: 10.1158/1078-0432.Ccr-16-0237 |
0.322 |
|
| 2016 |
Shaw Bagnall J, Byun S, Miyamoto DT, Kang JH, Maheswaran S, Stott SL, Toner M, Manalis SR. Deformability-based cell selection with downstream immunofluorescence analysis. Integrative Biology : Quantitative Biosciences From Nano to Macro. PMID 26999591 DOI: 10.1039/C5Ib00284B |
0.38 |
|
| 2016 |
Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, Desai R, Brannigan BW, Arora KS, Dahl DM, Sequist LV, Smith MR, Kapur R, Wu C, Shioda T, et al. Abstract IA09: Single cell RNA-sequencing of circulating tumor cells Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pmsclingen15-Ia09 |
0.616 |
|
| 2016 |
Saylor PJ, Lee RJ, Arora KS, Ting DT, Deshpande V, Rivera MN, Hu R, Wu C, Miyamoto DT. Abstract 4947: Branched chain RNAin situhybridization for the detection of androgen receptor splice variants within archival prostate cancer tissue Cancer Research. 76: 4947-4947. DOI: 10.1158/1538-7445.Am2016-4947 |
0.372 |
|
| 2016 |
Zheng Y, Miyamoto DT, Wittner BS, Sullivan JP, Aceto N, Jordan NV, Yu M, Karabacak NM, Comaills V, Morris R, Desai R, Desai N, Emmons E, Lee RJ, Wu C, et al. Abstract 2679: Induction of β-globin protects circulating tumor cells from oxidative stress during dissemination Cancer Research. 76: 2679-2679. DOI: 10.1158/1538-7445.Am2016-2679 |
0.585 |
|
| 2015 |
Shaw Bagnall J, Byun S, Begum S, Miyamoto DT, Hecht VC, Maheswaran S, Stott SL, Toner M, Hynes RO, Manalis SR. Deformability of Tumor Cells versus Blood Cells. Scientific Reports. 5: 18542. PMID 26679988 DOI: 10.1038/Srep18542 |
0.418 |
|
| 2015 |
Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, Desai R, Fox DB, Brannigan BW, Trautwein J, Arora KS, Desai N, Dahl DM, Sequist LV, Smith MR, et al. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science (New York, N.Y.). 349: 1351-6. PMID 26383955 DOI: 10.1126/Science.Aab0917 |
0.58 |
|
| 2015 |
Sarioglu AF, Aceto N, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto DT, Luo X, Bardia A, Wittner BS, Ramaswamy S, Shioda T, et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nature Methods. 12: 685-91. PMID 25984697 DOI: 10.1038/Nmeth.3404 |
0.515 |
|
| 2015 |
Sarioglu AF, Aceto N, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto DT, Luo X, Bardia A, Wittner BS, Ramaswamy S, Shioda T, et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters Nature Methods. 12: 685-691. DOI: 10.1038/nmeth.3404 |
0.439 |
|
| 2015 |
Miyamoto D, Zheng Y, Wittner B, Lee R, Zhu H, Broderick K, Desai R, Brannigan B, Arora K, Dahl D, Sequist L, Smith M, Kapur R, Wu C, Shioda T, et al. Single Cell RNA Profiling of Circulating Tumor Cells in Patients With Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: S104. DOI: 10.1016/J.Ijrobp.2015.07.250 |
0.596 |
|
| 2014 |
Ting DT, Wittner BS, Ligorio M, Vincent Jordan N, Shah AM, Miyamoto DT, Aceto N, Bersani F, Brannigan BW, Xega K, Ciciliano JC, Zhu H, MacKenzie OC, Trautwein J, Arora KS, et al. Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Reports. 8: 1905-18. PMID 25242334 DOI: 10.1016/J.Celrep.2014.08.029 |
0.594 |
|
| 2014 |
Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 158: 1110-22. PMID 25171411 DOI: 10.1016/J.Cell.2014.07.013 |
0.563 |
|
| 2014 |
Miyamoto DT, Sequist LV, Lee RJ. Circulating tumour cells-monitoring treatment response in prostate cancer. Nature Reviews. Clinical Oncology. 11: 401-12. PMID 24821215 DOI: 10.1038/Nrclinonc.2014.82 |
0.401 |
|
| 2014 |
Ting DT, Wittner BS, Shah AM, Miyamoto DT, Brannigan BW, Xega K, Ciciliano J, MacKenzie OC, Trautwein J, Shahid M, Ellis HL, Qu N, Bardeesy N, Rivera MN, Kapur R, et al. Abstract NG04: Diversity of circulating tumor cells in a mouse pancreatic cancer model identified by single cell RNA sequencing Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Ng04 |
0.599 |
|
| 2013 |
Miyamoto DT, Viswanathan AN. Concurrent chemoradiation for vaginal cancer. Plos One. 8: e65048. PMID 23762284 DOI: 10.1371/Journal.Pone.0065048 |
0.327 |
|
| 2013 |
Lee RJ, Saylor PJ, Michaelson MD, Rothenberg SM, Smas ME, Miyamoto DT, Gurski CA, Xie W, Maheswaran S, Haber DA, Goldin JG, Smith MR. A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3088-94. PMID 23553848 DOI: 10.1158/1078-0432.Ccr-13-0319 |
0.511 |
|
| 2013 |
Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E, Yu M, Chen PI, Morgan B, Trautwein J, Kimura A, Sengupta S, Stott SL, Karabacak NM, Barber TA, et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Science Translational Medicine. 5: 179ra47. PMID 23552373 DOI: 10.1126/Scitranslmed.3005616 |
0.606 |
|
| 2013 |
Haber DA, Yu M, Ozkumar E, Ting D, Miyamoto D, Lee R, Shah A, Bardia A, Stott S, Toner M, Maheswaran S. Abstract SY30-01: Molecular characterization of single circulating tumor cells. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Sy30-01 |
0.622 |
|
| 2013 |
Haber DA, Maheswaran S, Sequist L, Yu M, Ozkumur E, Ting D, Miyamoto D, Lee R, Shah A, Bardia A, Stott S, Toner M. Abstract PL06-04: Molecular characterization of circulating tumor cells. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-Pl06-04 |
0.62 |
|
| 2013 |
Jimenez R, Trautwein J, Efstathiou J, Mitin T, Maheswaran S, Haber D, Shipley W, Zietman A, Wu C, Miyamoto D. Feasibility of Gene Expression Signature Analysis in Prostate Cancer Biopsy Specimens to Predict Outcomes Following Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S669. DOI: 10.1016/J.Ijrobp.2013.06.1774 |
0.521 |
|
| 2012 |
Miyamoto DT, Lee RJ, Stott SL, Ting DT, Wittner BS, Ulman M, Smas ME, Lord JB, Brannigan BW, Trautwein J, Bander NH, Wu CL, Sequist LV, Smith MR, Ramaswamy S, et al. Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discovery. 2: 995-1003. PMID 23093251 DOI: 10.1158/2159-8290.Cd-12-0222 |
0.566 |
|
| 2012 |
Lee RJ, Michaelson MD, Saylor PJ, Gurski CA, Rothenberg SM, Miyamoto DT, Maheswaran S, Haber DA, Goldin JG, Smith MR. Investigator-sponsored trial of efficacy and tolerability of cabozantinib (cabo) at lower dose: A dose-finding study in men with castration-resistant prostate cancer (CRPC) and bone metastases. Journal of Clinical Oncology. 30: 4566-4566. DOI: 10.1200/Jco.2012.30.15_Suppl.4566 |
0.458 |
|
| 2011 |
Miyamoto DT, Harris JR. Molecular predictors of local tumor control in early-stage breast cancer. Seminars in Radiation Oncology. 21: 35-42. PMID 21134652 DOI: 10.1016/J.Semradonc.2010.08.005 |
0.36 |
|
| 2010 |
Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP, Gilman AJ, Lord JB, Winokur D, Springer S, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proceedings of the National Academy of Sciences of the United States of America. 107: 18392-7. PMID 20930119 DOI: 10.1073/Pnas.1012539107 |
0.606 |
|
| 2010 |
Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Science Translational Medicine. 2: 25ra23. PMID 20424012 DOI: 10.1126/scitranslmed.3000403 |
0.546 |
|
| 2010 |
Miyamoto D, Tanaka C, Viswanathan A. Concurrent Chemoradiation Improves Survival in Patients with Vaginal Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S120-S121. DOI: 10.1016/J.Ijrobp.2010.07.306 |
0.324 |
|
| 2004 |
Miyamoto DT, Perlman ZE, Burbank KS, Groen AC, Mitchison TJ. The kinesin Eg5 drives poleward microtubule flux in Xenopus laevis egg extract spindles. The Journal of Cell Biology. 167: 813-8. PMID 15583027 DOI: 10.1083/Jcb.200407126 |
0.696 |
|
| 2004 |
Groen AC, Cameron LA, Coughlin M, Miyamoto DT, Mitchison TJ, Ohi R. XRHAMM functions in ran-dependent microtubule nucleation and pole formation during anastral spindle assembly. Current Biology : Cb. 14: 1801-11. PMID 15498487 DOI: 10.1016/J.Cub.2004.10.002 |
0.717 |
|
| 2003 |
Miyamoto DT, Perlman ZE, Mitchison TJ, Shirasu-Hiza M. Dynamics of the mitotic spindle--potential therapeutic targets. Progress in Cell Cycle Research. 5: 349-60. PMID 14593729 |
0.711 |
|
| 2002 |
McDonald WH, Ohi R, Miyamoto DT, Mitchison TJ, Yates JR. Comparison of three directly coupled HPLC MS/MS strategies for identification of proteins from complex mixtures: Single-dimension LC-MS/MS, 2-phase MudPIT, and 3-phase MudPIT International Journal of Mass Spectrometry. 219: 245-251. DOI: 10.1016/S1387-3806(02)00563-8 |
0.439 |
|
| 2001 |
Haggarty SJ, Mayer TU, Miyamoto DT, Fathi R, King RW, J. Mitchison T, Schreiber SL. Erratum to ‘Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis’ Chemistry & Biology. 8: 1265. DOI: 10.1016/S1074-5521(01)00083-7 |
0.518 |
|
| 2000 |
Haggarty SJ, Mayer TU, Miyamoto DT, Fathi R, King RW, Mitchison TJ, Schreiber SL. Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chemistry & Biology. 7: 275-86. PMID 10780927 DOI: 10.1016/S1074-5521(00)00101-0 |
0.645 |
|
| Show low-probability matches. |